High concentrated protein compositions for preventing tissue adhesion
AssigneeOmrix Biopharmaceuticals Ltd.
InventorsInbar Gahali-Sass, Israel Nur, Erez Ilan, Ronen Eavri
Life of this patent
Estimating the term…
Loading patent…
AssigneeOmrix Biopharmaceuticals Ltd.
InventorsInbar Gahali-Sass, Israel Nur, Erez Ilan, Ronen Eavri
Estimating the term…
Disclosed herein is an anti-adhesion kit comprised of: (i) a fibrinogen solution component comprising: fibrinogen at a concentration of about 5 to 25 mg/ml; and free calcium ions at a concentration ranging from 0.1 μM to 1 mM; and (ii) a thrombin component containing thrombin. Further disclosed is an anti-adhesion kit comprised of: (i) a fibrinogen solution component containing fibrinogen at a concentration of 8% to 25% of total protein by weight, and optionally free calcium ions at a concentration ranging from 0.1 μM to 1 mM; wherein a total protein concentration ranges from about 80 to 120 mg/ml; and (ii) a thrombin component containing thrombin. Methods of using the kits e.g., to provide anti-adhesion curable compositions are also disclosed.
A two-component composition for adhesion prevention comprising:
Dependencies are inferred from the claim text.